These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30626655)

  • 1. Assessment of disease progression in dysferlinopathy: A 1-year cohort study.
    Moore U; Jacobs M; James MK; Mayhew AG; Fernandez-Torron R; Feng J; Cnaan A; Eagle M; Bettinson K; Rufibach LE; Lofra RM; Blamire AM; Carlier PG; Mittal P; Lowes LP; Alfano L; Rose K; Duong T; Berry KM; Montiel-Morillo E; Pedrosa-Hernández I; Holsten S; Sanjak M; Ashida A; Sakamoto C; Tateishi T; Yajima H; Canal A; Ollivier G; Decostre V; Mendez JB; Sánchez-Aguilera Praxedes N; Thiele S; Siener C; Shierbecker J; Florence JM; Vandevelde B; DeWolf B; Hutchence M; Gee R; Prügel J; Maron E; Hilsden H; Lochmüller H; Grieben U; Spuler S; Tesi Rocha C; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Harms M; Pestronk A; Krause S; Schreiber-Katz O; Walter MC; Paradas C; Hogrel JY; Stojkovic T; Takeda S; Mori-Yoshimura M; Bravver E; Sparks S; Díaz-Manera J; Bello L; Semplicini C; Pegoraro E; Mendell JR; Bushby K; Straub V;
    Neurology; 2019 Jan; 92(5):e461-e474. PubMed ID: 30626655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach.
    Mayhew AG; James MK; Moore U; Sutherland H; Jacobs M; Feng J; Lowes LP; Alfano LN; Muni Lofra R; Rufibach LE; Rose K; Duong T; Bello L; Pedrosa-Hernández I; Holsten S; Sakamoto C; Canal A; Sánchez-Aguilera Práxedes N; Thiele S; Siener C; Vandevelde B; DeWolf B; Maron E; Gordish-Dressman H; Hilsden H; Guglieri M; Hogrel JY; Blamire AM; Carlier PG; Spuler S; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Pestronk A; Walter MC; Paradas C; Stojkovic T; Mori-Yoshimura M; Bravver E; Díaz-Manera J; Pegoraro E; Mendell JR; Straub V
    Front Neurol; 2022; 13():828525. PubMed ID: 35359643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
    Mazzone E; Vasco G; Sormani MP; Torrente Y; Berardinelli A; Messina S; D'Amico A; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Bonfiglio S; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Gasperini S; Previtali S; Napolitano S; Martinelli D; Bruno C; Vita G; Comi G; Bertini E; Mercuri E
    Neurology; 2011 Jul; 77(3):250-6. PubMed ID: 21734183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Mitochondrial Myopathy-Composite Assessment Tool.
    Flickinger J; Fan J; Wellik A; Ganetzky R; Goldstein A; Muraresku CC; Glanzman AM; Ballance E; Leonhardt K; McCormick EM; Soreth B; Nguyen S; Gornish J; George-Sankoh I; Peterson J; MacMullen LE; Vishnubhatt S; McBride M; Haas R; Falk MJ; Xiao R; Zolkipli-Cunningham Z
    JCSM Clin Rep; 2021 Oct; 6(4):109-127. PubMed ID: 35071983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale.
    Jacobs MB; James MK; Lowes LP; Alfano LN; Eagle M; Muni Lofra R; Moore U; Feng J; Rufibach LE; Rose K; Duong T; Bello L; Pedrosa-Hernández I; Holsten S; Sakamoto C; Canal A; Sanchez-Aguilera Práxedes N; Thiele S; Siener C; Vandevelde B; DeWolf B; Maron E; Guglieri M; Hogrel JY; Blamire AM; Carlier PG; Spuler S; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Pestronk A; Walter MC; Paradas C; Stojkovic T; Mori-Yoshimura M; Bravver E; Díaz-Manera J; Pegoraro E; Mendell JR; ; Mayhew AG; Straub V
    Ann Neurol; 2021 May; 89(5):967-978. PubMed ID: 33576057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.
    Mazzone E; Martinelli D; Berardinelli A; Messina S; D'Amico A; Vasco G; Main M; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Carlesi A; Bonetti AM; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Pasquini E; Bruno C; Vita G; de Waure C; Bertini E; Mercuri E
    Neuromuscul Disord; 2010 Nov; 20(11):712-6. PubMed ID: 20634072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys.
    Stimpson G; Ridout D; Wolfe A; Milev E; O'Reilly E; Manzur A; Sarkozy A; Muntoni F; Cole TJ; Baranello G;
    J Neuromuscul Dis; 2024; 11(1):153-166. PubMed ID: 37980680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine
    van de Velde NM; Koeks Z; Signorelli M; Verwey N; Overzier M; Bakker JA; Sajeev G; Signorovitch J; Ricotti V; Verschuuren J; Brown K; Spitali P; Niks EH
    Neurology; 2023 Feb; 100(9):e975-e984. PubMed ID: 36849458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water T2 could predict functional decline in patients with dysferlinopathy.
    Moore U; Caldas de Almeida Araújo E; Reyngoudt H; Gordish-Dressman H; Smith FE; Wilson I; James M; Mayhew A; Rufibach L; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Pestronk A; Walter MC; Paradas C; Stojkovic T; Mori-Yoshimura M; Bravver E; Pegoraro E; Mendell JR; ; Bushby K; Blamire AM; Straub V; Carlier PG; Diaz-Manera J
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2888-2897. PubMed ID: 36058852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.
    Muntoni F; Domingos J; Manzur AY; Mayhew A; Guglieri M; ; Sajeev G; Signorovitch J; Ward SJ
    PLoS One; 2019; 14(9):e0221097. PubMed ID: 31479456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.
    Meilleur KG; Jain MS; Hynan LS; Shieh CY; Kim E; Waite M; McGuire M; Fiorini C; Glanzman AM; Main M; Rose K; Duong T; Bendixen R; Linton MM; Arveson IC; Nichols C; Yang K; Fischbeck KH; Wagner KR; North K; Mankodi A; Grunseich C; Hartnett EJ; Smith M; Donkervoort S; Schindler A; Kokkinis A; Leach M; Foley AR; Collins J; Muntoni F; Rutkowski A; Bönnemann CG
    Neuromuscul Disord; 2015 Jan; 25(1):43-54. PubMed ID: 25307854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
    Mazzone ES; Pane M; Sormani MP; Scalise R; Berardinelli A; Messina S; Torrente Y; D'Amico A; Doglio L; Viggiano E; D'Ambrosio P; Cavallaro F; Frosini S; Bello L; Bonfiglio S; De Sanctis R; Rolle E; Bianco F; Magri F; Rossi F; Vasco G; Vita G; Motta MC; Donati MA; Sacchini M; Mongini T; Pini A; Battini R; Pegoraro E; Previtali S; Napolitano S; Bruno C; Politano L; Comi GP; Bertini E; Mercuri E
    PLoS One; 2013; 8(1):e52512. PubMed ID: 23326337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II.
    Werlauff U; Fynbo Steffensen B
    Disabil Rehabil; 2014; 36(25):2120-6. PubMed ID: 24579651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of strength testing modalities in dysferlinopathy.
    Reash NF; James MK; Alfano LN; Mayhew AG; Jacobs M; Iammarino MA; Holsten S; Sakamoto C; Tateishi T; Yajima H; Duong T; de Wolf B; Gee R; Bharucha-Goebel DX; Bravver E; Mori-Yoshimura M; Bushby K; Rufibach LE; Straub V; Lowes LP;
    Muscle Nerve; 2022 Aug; 66(2):159-166. PubMed ID: 35506767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy.
    Ayyar Gupta V; Pitchforth JM; Domingos J; Ridout D; Iodice M; Rye C; Chesshyre M; Wolfe A; Selby V; Mayhew A; Mazzone ES; Ricotti V; Hogrel JY; Niks EH; de Groot I; Servais L; Straub V; Mercuri E; Manzur AY; Muntoni F;
    PLoS One; 2023; 18(4):e0283669. PubMed ID: 37099511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of clinical evaluation with life quality and mental status in a Chinese cohort with dysferlinopathy.
    Feng X; Liu C; Xi J; Sun C; Yue D; Zhu W; Li J; Liang Z; Lu J; Luo S
    J Clin Neurosci; 2020 Nov; 81():259-264. PubMed ID: 33222926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power grip, pinch grip, manual muscle testing or thenar atrophy - which should be assessed as a motor outcome after carpal tunnel decompression? A systematic review.
    Geere J; Chester R; Kale S; Jerosch-Herold C
    BMC Musculoskelet Disord; 2007 Nov; 8():114. PubMed ID: 18028538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.
    Lerario A; Bonfiglio S; Sormani M; Tettamanti A; Marktel S; Napolitano S; Previtali S; Scarlato M; Natali-Sora M; Mercuri E; Bresolin N; Mongini T; Comi G; Gatti R; Ciceri F; Cossu G; Torrente Y
    BMC Neurol; 2012 Sep; 12():91. PubMed ID: 22974002
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.